Scientific publications for BioPredictive non-invasive diagnostics

Peer-reviewed studies validating BioPredictive blood-test diagnostics for liver disease — from first-in-class development cohorts to long-term meta-analyses.

4/433 Matches for
“NNS, needed to screen”

“NNS, needed to screen” Clear all

  1. External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis B.

    Poynard T et al. · Gastro Hep Adv · 2022 Match 100

    …A post hoc analysis compared the number of patients needed to screen…

    FibroTest LCR1 LCR2 Surveillance-FibroTest +1

  2. External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV.

    Poynard T et al. · JHEP Rep · 2021 Match 88

    …The aim was to externally validate the LCR1-LCR2 in patients with…

    LCR1 LCR2 HCV

  3. LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis. Key publication

    Poynard T et al. · Aliment Pharmacol Ther · 2019 Match 75

    …that is 12 patients needed to screen one cancer. The negative predictive…

    LCR1 LCR2 Alcohol HBV +4

  4. LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis.

    Poynard T et al. · Aliment Pharmacol Ther · 2019 Match 63

    …that is 12 patients needed to screen one cancer. The negative predictive…

    FibroTest LCR1 LCR2 Alcohol +3

Showing the full result list. The page is server-rendered and not paginated.